𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and Safety of Canagliflozin (CANA) in Subjects with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) Over 52 Weeks

✍ Scribed by Yale, Jean-Francois; Bakris, George; Cariou, Bertrand; Nieto, Javier; Wajs, Ewa; Figueroa, Katherine; Jiang, Joel; Usiskin, Keith; Meininger, Gary


Book ID
122895786
Publisher
Canadian Diabetes Association
Year
2013
Tongue
English
Weight
61 KB
Volume
37
Category
Article
ISSN
1499-2671

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES